Inflammatory bowel disease is one of those conditions that has a way of challenging practitioners across species. The diagnostic process is rarely straightforward, the underlying causes remain incompletely understood, and the available treatments do not always deliver the resolution that patients and their caregivers are hoping for. The condition affects dogs, cats, horses, and humans, and in each of these populations, it tends to follow a similar pattern: inflammation infiltrates the intestinal lining, disrupts normal tissue architecture, damages the intestinal villi, and compromises the body’s ability to digest and absorb nutrients effectively.
For a long time, diet and stress were considered the primary drivers of IBD. The current understanding is more nuanced. Researchers now recognize immune dysregulation as the central mechanism, with diet and stress functioning as risk factors that aggravate an underlying pathologic process rather than cause it. That distinction matters clinically, because it shifts attention toward the immune and nervous systems as the most meaningful targets for intervention.
Conventional treatment protocols, including anti-inflammatory and immunomodulatory medications, dietary modification, antibiotics, nutraceuticals, and vitamin supplementation, provide meaningful relief for many patients. A substantial number, however, continue to experience symptoms despite these measures. That persistent gap between available therapies and adequate clinical resolution is precisely why integrative approaches, and medical acupuncture in particular, deserve serious attention in the management of IBD.
The Vagus Nerve as a Central Player in IBD Pathophysiology
Understanding why acupuncture has clinical relevance in IBD requires understanding what the vagus nerve does and what happens when it stops doing it well.
The vagus nerve is a major component of the parasympathetic nervous system. It originates in the brainstem and travels extensively throughout the thoracic and abdominal cavities, innervating nearly every internal organ. Its name derives from the Latin word for wanderer, an apt description for a structure with such broad anatomical reach. Roughly eighty percent of its fibers are afferent, meaning they carry sensory information from the periphery to the brainstem rather than the other way around. This makes the vagus nerve primarily a messenger, continuously relaying information about physiologic conditions in the body to central autonomic processing centers such as the nucleus tractus solitarius.
Among the signals the vagus nerve monitors are three of the most significant drivers of chronic disease: oxidative stress, inflammation, and sympathetic overactivation. When vagal function is intact, incoming signals from these sources trigger what is known as the vagal anti-inflammatory reflex. This is a coordinated, multi-pronged response that works to bring the body back toward homeostasis. It includes neuroendocrine effects on the hypothalamic-pituitary-adrenal axis that increase cortisol secretion, neuroimmunomodulatory influences on immune cells such as monocytes that inhibit the synthesis of pro-inflammatory cytokines, and reversal of sympathetic-induced vasoconstriction that improves tissue oxygenation and circulation. When vagal activity is impaired, these regulatory processes weaken, and the chronic intestinal inflammation characteristic of IBD can become self-sustaining.
The Brain-Gut-Microbiota Axis
The vagus nerve does not operate in isolation within the gastrointestinal system. It functions as part of a broader communication network that includes the enteric nervous system, the intestinal microbiome, and the central nervous system, a network researchers have termed the brain-gut-microbiota axis.
Gut microbiota communicates with the enteric nervous system and with the brain through neuroendocrine and neuroimmune pathways, while vagal signaling relays information bidirectionally between the gut and the central nervous system. Disruptions in this network contribute not only to gastrointestinal dysfunction but also to behavioral and neurologic changes. Research in animal models has shown that the absence or disruption of normal intestinal microbial populations produces neurochemical alterations in the brain and behavioral changes that would not be predicted from a purely gastrointestinal perspective. Microbiota alterations can modulate autonomic nervous system activity, immune signaling, and central nervous system function through vagal pathways, sending signals to the brain and receiving them in return.
Some vagal afferent fibers travel directly to the tips of jejunal villi, where they come into close contact with intestinal mucosal mast cells. This microanatomical arrangement provides a direct communication channel between the gastrointestinal mucosa and the central nervous system. Vagal fibers interact with enteric neurons rather than connecting directly to gut macrophages, meaning that enteric neurons serve as the mediating layer through which vagal efferent activity regulates intestinal immune responses. Pro-inflammatory cytokines stimulate vagal afferents, which in turn activate vagal efferents, which then prevent tissue macrophages from releasing further pro-inflammatory cytokines including tumor necrosis factor. The system is self-regulating when it functions properly. When vagal activity is insufficient, that regulation breaks down.
How Medical Acupuncture Addresses Vagal Dysregulation
Medical acupuncture operates through neuromodulation, which is the process of altering nervous system activity through targeted stimulation of peripheral nerves. When acupuncture needles stimulate specific anatomical sites, sensory signals travel through peripheral nerves to the spinal cord and brainstem, activating regulatory responses within the autonomic and central nervous systems. In the context of IBD, this mechanism is directly relevant because vagal dysregulation sits at the center of the pathophysiology.
Acupuncture has been shown to increase vagal activity and support its return to function, allowing the body’s endogenous regulatory capacity to more effectively address the inflammatory disturbance. A 2019 review published in Inflammatory Bowel Diseases documented that acupuncture decreases disease activity and inflammation through increased vagal activity in IBD, and also demonstrated beneficial roles in the regulation of gut dysbiosis, intestinal barrier function, visceral hypersensitivity, gut motor dysfunction, and the depression and anxiety that frequently accompany chronic gastrointestinal disease. A systematic review and meta-analysis published in Complementary Therapies in Medicine similarly found evidential support for acupuncture’s ability to relieve IBD symptoms and modulate blood levels of inflammatory markers.
Approximately half of human patients with IBD seek integrative medical care, and acupuncture is among the most commonly pursued options. Its evidence base is still developing and would benefit from more standardized methodology and larger trials, but the neurophysiologic rationale for its effects in IBD is well-grounded and mechanistically coherent in ways that warrant its serious consideration alongside conventional management strategies.
Anatomical Targets and the Science Behind Their Selection
Designing an effective acupuncture protocol for IBD is not a matter of selecting traditional points by convention. It requires identifying stimulation sites whose innervation can be expected to produce specific neurophysiologic effects relevant to the condition being treated. This science-based approach to point selection is what distinguishes medical acupuncture from approaches rooted in historical or metaphysical frameworks, and it is the foundation on which CuraCore Canada‘s curriculum is built.
Two primary target areas are relevant to IBD. The first is Stomach 36, known by its traditional name Zusanli, located near the motor point of the cranial tibialis muscle on the pelvic limb and innervated by the deep fibular nerve. Electroacupuncture at this site in rodent IBD models has produced reversal of inflammation and leukocyte infiltration, normalization of elevated inflammatory cytokines, and normalization of the colon’s tight junctions. Additional research in colitis models demonstrated that electroacupuncture at Stomach 36 relieved somatic pain by inhibiting sympathetic sprouting into the dorsal root ganglion and reducing surface neurogenic inflammation, suggesting clinical value for IBD patients experiencing referred somatic pain. Pairing Stomach 36 with Sanyinjiao, located on the crus and supplied by the tibial nerve, has been associated with attenuation of anxiety and depression-like behavior in colitis model rats, addressing the psychological dimensions of chronic gastrointestinal disease that pharmacologic management alone frequently does not resolve.
The second target area involves paraspinal and trunk points that address the musculoskeletal discomfort commonly accompanying intestinal inflammation. Visceral nociceptive signals from the gastrointestinal tract converge within spinal cord segments that also receive somatic sensory input from the thoracic, lumbar, and sacral regions. This viscerosomatic convergence explains why animals with IBD often present with apparent back pain and postural changes that are not independently musculoskeletal in origin. By stimulating somatic afferents at paraspinal sites corresponding to these spinal segments, acupuncture protocols can address the referred somatic component of IBD simultaneously with the visceral and autonomic components.
It is also worth noting that massage and photomedicine, including laser therapy and light-emitting diode therapy, can augment or in some cases substitute for acupuncture in this clinical context. Both modalities are capable of activating and supporting vagal nerve function, making them meaningful additions to or alternatives within a multimodal integrative treatment plan.
Putting This Into Practice
For veterinary practitioners, the clinical picture that emerges from this research is actionable. Animals presenting with IBD who have incomplete responses to conventional management, or for whom long-term pharmacologic therapy carries risks that warrant mitigation, are reasonable candidates for medical acupuncture as an adjunctive approach. The assessment process begins with the same careful observation that informs all integrative rehabilitation work: evaluating posture, movement, areas of muscular tension or tenderness in the thoracolumbar region, and the broader clinical picture that emerges when the patient is considered as a whole system rather than a collection of isolated symptoms.
A thorough neuroanatomic understanding of point selection allows the practitioner to design protocols that directly target vagal activity, intestinal barrier function, and the somatic pain referral patterns associated with visceral inflammation. Rather than a parallel or competing approach to conventional care, it’s an extension of it, one grounded in the same physiologic systems that conventional diagnostics and treatments are designed to address.
Practitioners who are already working in integrative rehabilitation or medical acupuncture will recognize the overlapping mechanisms at play here. The same neurophysiologic principles that apply to pain management, musculoskeletal rehabilitation, and sensorimotor retraining are directly relevant to the autonomic and immune dysregulation that underlies IBD. For those who have not yet incorporated gastrointestinal conditions into their integrative practice, this is a well-supported clinical application worth developing.
Continuing Your Education With CuraCore Canada
Whether you are currently enrolled in a CuraCore Canada program, a graduate applying integrative techniques in practice, or a veterinary professional exploring what science-based integrative medicine has to offer, the neurophysiology of IBD reflects the kind of clinically grounded, mechanistically sound content that runs through all of our coursework.
CuraCore Canada offers training in medical acupuncture, integrative rehabilitation, medical massage, botanical medicine, and photomedicine, all taught through the lens of neuroscience, anatomy, and peer-reviewed clinical research. Our programs are designed for practicing veterinary professionals who want to expand their clinical capabilities in ways that are evidence-informed, practically applicable, and consistent with the standards of modern veterinary medicine.
Further Reading
A more detailed examination of acupuncture and IBD, including additional clinical context and discussion of the original research, is available in Dr. Robinson’s column for Veterinary Practice News: “Is Acupuncture Effective for IBD?”
Practitioners who want to go deeper into the evidence and the clinical reasoning behind the protocol design discussed here will find that piece a useful companion to this one.